date,title,source
Oct-29-18,Neurocrine Biosciences (NBIX) Q3 Earnings Preview: What to Look Out For,Zacks
Oct-31-18,Neurocrine (NBIX) to Report Q3 Earnings: What's in the Cards?,Zacks
Nov-05-18,Neurocrine Biosciences (NBIX) Q3 Earnings and Revenues Top Estimates,Zacks
Nov-05-18,Neurocrine: 3Q Earnings Snapshot,Associated Press
Nov-05-18,Neurocrine Biosciences Reports Third Quarter 2018 Financial Results,PR Newswire
Nov-05-18,Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Exelixis,ACCESSWIRE
Nov-07-18,Neurocrine Biosciences to Present at the Jefferies 2018 London Healthcare Conference,PR Newswire
Nov-07-18,Does Neurocrine Biosciences Incs (NASDAQ:NBIX) Debt Level Pose A Problem?,Simply Wall St.
Nov-09-18,"Report: Developing Opportunities within Louisiana-Pacific, Neurocrine Biosciences, Tahoe Resources, Loews, Quotient Technology, and Evolent Health  Future Expectations, Projections Moving into 2018",GlobeNewswire
Nov-12-18,5 Pharma Stocks to Stay Away From,InvestorPlace
Nov-14-18,AbbVie Presents Positive Phase 3 Data Demonstrating Investigational Elagolix Reduces Heavy Menstrual Bleeding in Women with Uterine Fibroids at 2018 AAGL Global Congress,PR Newswire
Nov-15-18,Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Amarin,ACCESSWIRE
Nov-16-18,Neurocrine (NBIX) Catches Eye: Stock Jumps 6.5%,Zacks
Nov-27-18,3 Top Biotech Stocks to Buy Right Now,Motley Fool
Dec-12-18,"Why Under Armour, Neurocrine Biosciences, and XPO Logistics Slumped Today",Motley Fool
Dec-12-18,Why Neurocrine Biosciences Is Tanking,Motley Fool
Dec-12-18,Neurocrine Biosciences says trial of Tourette syndrome treatment missed primary goal,MarketWatch
Dec-12-18,Neurocrine Biosciences Announces Topline Data from Phase IIb T-Force GOLD Study Demonstrating Valbenazine Did Not Meet Primary Endpoint in Pediatric Patients with Tourette Syndrome,PR Newswire
Dec-13-18,Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Synergy Pharmaceuticals,ACCESSWIRE
Dec-14-18,Do Options Traders Know Something About Neurocrine Biosciences (NBIX) Stock We Don't?,Zacks
Dec-31-18,4 of the Fastest Growing Biotech Stocks in 2019,Motley Fool
Jan-02-19,Neurocrine Biosciences to Present at the 37th Annual J.P. Morgan Healthcare Conference,PR Newswire
Jan-07-19,"Neurocrine Gives Ingrezza Sales View, Updates on Pipeline",Zacks
Jan-07-19,Neurocrine Biosciences Is a Pharma Stock to Watch,InvestorPlace
Jan-07-19,Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Loxo Oncology,ACCESSWIRE
Jan-10-19,5 Biotech Stocks That Could Face M&A Next!,InvestorPlace
Jan-11-19,Biotech Stocks Are Enjoying Their Best-Ever Start to the Year,Bloomberg
Jan-11-19,"Is Neurocrine Biosciences, Inc.s (NASDAQ:NBIX) CEO Overpaid Relative To Its Peers?",Simply Wall St.
Jan-14-19,Today's Research Reports on Trending Tickers: Moderna and Neurocrine Biosciences,ACCESSWIRE
Jan-15-19,Heres your guide to the upcoming biotechnology takeover wave,MarketWatch
Jan-15-19,Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2018 Financial Results,PR Newswire
Jan-25-19,"Analysis: Positioning to Benefit within Neurocrine Biosciences, CONMED, TripAdvisor, Ryder System, Nordstrom, and Express  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Jan-28-19,Will Neurocrine Biosciences Continue to Surge Higher?,Zacks
Jan-29-19,Here's Why Voyager Therapeutics Stock Soared as Much as 62.9% Today,Motley Fool
Jan-29-19,Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,Zacks
Jan-29-19,Neurocrine Biosciences and Voyager Therapeutics Form Strategic Development and Commercialization Collaboration for Parkinsons Disease and Friedreichs Ataxia,GlobeNewswire
Jan-31-19,Here are Boston-area biotechs pursuing Parkinson's treatments,American City Business Journals
Feb-05-19,Neurocrine Biosciences Inc (NBIX) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-05-19,Neurocrine Biosciences (NBIX) Beats Q4 Earnings Estimates,Zacks
Feb-05-19,Neurocrine: 4Q Earnings Snapshot,Associated Press
Feb-05-19,Neurocrine Biosciences Reports Fourth Quarter and Year-End 2018 Financial Results,PR Newswire
Feb-05-19,"Neurocrine Biosciences, Inc. to Host Earnings Call",ACCESSWIRE
Feb-05-19,"The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results",Benzinga
Feb-06-19,Edited Transcript of NBIX earnings conference call or presentation 5-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
Feb-06-19,"The Daily Biotech Pulse: Paratek Launches Antibiotic In US, Eli Lilly Earnings, Catabasis Offering",Benzinga
Feb-08-19,"Neurocrine Biosciences Inc (NBIX) Files 10-K for the Fiscal Year Ended on December 31, 2018",GuruFocus.com
Feb-12-19,CTLT vs. NBIX: Which Stock Should Value Investors Buy Now?,Zacks
Feb-21-19,Edited Transcript of NBIX earnings conference call or presentation 5-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
Feb-22-19,Voyager Therapeutics stock jumps on 2nd Parkinson's deal,American City Business Journals
Feb-28-19,"Why Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Is An Attractive Investment To Consider",Simply Wall St.
Mar-01-19,Why These 2 Biotech Stocks Might Be Next On The Takeover List,Investor's Business Daily
Mar-05-19,Neurocrine Biosciences to Present at Upcoming Healthcare Conferences,PR Newswire
Mar-07-19,Stocks Slide for Third Straight Day,Zacks
Mar-12-19,Neurocrine Biosciences Reports Positive Interim Results from Phase II Study of NBI-74788 in Adults with Classic Congenital Adrenal Hyperplasia,PR Newswire
